The sooner they can come up with a solution the better.
A new report in the journal Nature Reviews Clinical Oncology suggests that we could be inching closer to using aspirin as part of clinical guidelines in cancer prevention.
The U.S. Preventive Services Task Force encourages an aspirin regimen for some patients to prevent heart problems and strokes.
Aspirin has also been shown to reduce the risk of colorectal cancer and colorectal polyps. Although taking aspirin daily has some promising benefits, it can also raise the risk of gastrointestinal bleeding.
The report released this week looked at recent studies of aspirin’s impact on cancer prevention. In March, two studies published in the Lancet and one in Lancet Oncology suggested that aspirin could have protective effects against various types of cancer.
View original post 228 more words